Table of contents
Volume 80, Issue 5-6
Published online 23 April 1999 (629-926)
Regular Articles
The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects FREE
G A P Hospers, E A Eisenhauer and E G E de Vries
Br J Cancer 80: 629-638; doi:10.1038/sj.bjc.6690404
Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules FREE
A Martayan, R Fraioli, E Giorda, A Setini, G Ciccarelli, L Delfino, G B Ferrara and P Giacomini
Br J Cancer 80: 639-649; doi:10.1038/sj.bjc.6690405
Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture FREE
J D Bergström, A Hermansson, T Diaz de Ståhl and N-E Heldin
Br J Cancer 80: 650-656; doi:10.1038/sj.bjc.6690406
Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-
in human prostate cancer cells FREE
D Seth, K Shaw, J Jazayeri and P J Leedman
Br J Cancer 80: 657-669; doi:10.1038/sj.bjc.6690407
Loss of functional pRB is not a ubiquitous feature of B-cell malignancies FREE
A J Sinclair and V Frost
Br J Cancer 80: 670-675; doi:10.1038/sj.bjc.6690408
Rodent fibroblast model for studies of response of malignant cells to exogenous 5-aminolevulinic acid FREE
G Li, M R Szewczuk, L Raptis, J G Johnson, G E Weagle, R H Pottier and J C Kennedy
Br J Cancer 80: 676-684; doi:10.1038/sj.bjc.6690409
Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines FREE
K E Wilson, J M S Bartlett, E P Miller, J F Smyth, P Mullen, W R Miller and S P Langdon
Br J Cancer 80: 685-692; doi:10.1038/sj.bjc.6690410
Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells FREE
M Pruschy, H Resch, Y-Q Shi, N Aalame, C Glanzmann and S Bodis
Br J Cancer 80: 693-698; doi:10.1038/sj.bjc.6690411
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin FREE
B Cenni, H-K Kim, G J Bubley, S Aebi, D Fink, B A Teicher, S B Howell and R D Christen
Br J Cancer 80: 699-704; doi:10.1038/sj.bjc.6690412
Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon- FREE
W-C Hung and L-Y Chuang
Br J Cancer 80: 705-710; doi:10.1038/sj.bjc.6690413
Caspase-3 activation during apoptosis caused by glutathione–doxorubicin conjugate FREE
T Asakura, T Sawai, Y Hashidume, Y Ohkawa, S Yokoyama and K Ohkawa
Br J Cancer 80: 711-715; doi:10.1038/sj.bjc.6690414
Thalidomide increases both intra-tumoural tumour necrosis factor- production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid FREE
Z Cao, W R Joseph, W L Browne, K G Mountjoy, B D Palmer, B C Baguley and L-M Ching
Br J Cancer 80: 716-723; doi:10.1038/sj.bjc.6690415
Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts FREE
M A Konerding, W Malkusch, B Klapthor, C van Ackern, E Fait, S A Hill, C Parkins, D J Chaplin, M Presta and J Denekamp
Br J Cancer 80: 724-732; doi:10.1038/sj.bjc.6690416
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas FREE
K Airola, T Karonen, M Vaalamo, K Lehti, J Lohi, A-L Kariniemi, J Keski-Oja and U K Saarialho-Kere
Br J Cancer 80: 733-743; doi:10.1038/sj.bjc.6690417
Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC FREE
L H P Murrer, K M Hebeda, J P A Marijnissen and W M Star
Br J Cancer 80: 744-755; doi:10.1038/sj.bjc.6690418
Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity FREE
T Glaser, S Winter, P Groscurth, H Safayhi, E-R Sailer, H P T Ammon, M Schabet and M Weller
Br J Cancer 80: 756-765; doi:10.1038/sj.bjc.6690419
A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients FREE
E Hammerlid, M Ahlner-Elmqvist, K Bjordal, A Biörklund, J Evensen, M Boysen, M Jannert, S Kaasa, M Sullivan and T Westin
Br J Cancer 80: 766-774; doi:10.1038/sj.bjc.6690420
Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion FREE
Y Nio, H Nagami, K Tamura, M Tsubono, M Nio, M Sato, K Kawabata, H Hayashi, T Shiraishi, S Imai, T Tsuchitani, J Mizuta, M Nakagawa and M Fukumoto
Br J Cancer 80: 775-785; doi:10.1038/sj.bjc.6690421
A randomized phase II trial of 5-fluorouracil, with or without human interferon-
, for advanced colorectal cancer FREE
A Villar-Grimalt, M T Candel, B Massuti, J Lizón, B Sánchez, A Frau, B Gorostidi and R Goedkoop
Br J Cancer 80: 786-791; doi:10.1038/sj.bjc.6690422
The development of a structured rating schedule (the BAS) to assess skills in breaking bad news FREE
S J Miller, T Hope and D C Talbot
Br J Cancer 80: 792-800; doi:10.1038/sj.bjc.6690423
Long-term effects on sexual function and fertility after treatment of testicular cancer FREE
J T Hartmann, C Albrecht, H-J Schmoll, M A Kuczyk, C Kollmannsberger and C Bokemeyer
Br J Cancer 80: 801-807; doi:10.1038/sj.bjc.6690424
Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease FREE
E A Shafford, J E Kingston, J C Healy, J A W Webb, P N Plowman and R H Reznek
Br J Cancer 80: 808-814; doi:10.1038/sj.bjc.6690425
Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer FREE
C C Earle and W K Evans
Br J Cancer 80: 815-820; doi:10.1038/sj.bjc.6690426
Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene FREE
D S Liscia, R Morizio, T Venesio, C Palenzona, M Donadio and R Callahan
Br J Cancer 80: 821-826; doi:10.1038/sj.bjc.6690427
Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers FREE
J Fujimoto, H Sakaguchi, R Hirose, S Ichigo and T Tamaya
Br J Cancer 80: 827-833; doi:10.1038/sj.bjc.6690428
New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology FREE
K Dolan, R Sutton, S J Walker, A I Morris, F Campbell and E M I Williams
Br J Cancer 80: 834-842; doi:10.1038/sj.bjc.6690429
Frequent allelic losses at 11q24.1–q25 in young women with breast cancer: association with poor survival FREE
M Gentile, K Olsen, M Dufmats and S Wingren
Br J Cancer 80: 843-849; doi:10.1038/sj.bjc.6690430
Deletion mapping of chromosome 16q in hepatocellular carcinoma FREE
Z Piao, C Park, J J Kim and H Kim
Br J Cancer 80: 850-854; doi:10.1038/sj.bjc.6690431
Propylnitrosourea-induced T-lymphomas in LEXF RI strains of rats: genetic analysis FREE
L-M Lu, H Shisa, J-i Tanuma and H Hiai
Br J Cancer 80: 855-861; doi:10.1038/sj.bjc.6690432
Comparative genomic hybridization and chromosomal instability in solid tumours FREE
P H Rooney, G I Murray, D A J Stevenson, N E Haites, J Cassidy and H L McLeod
Br J Cancer 80: 862-873; doi:10.1038/sj.bjc.6690433
Identification of women with early breast cancer by analysis of p43-positive lymphocytes FREE
L Auerbach, M Hellan, M Stierer, A C Rosen, C Ausch, R Obwegeser, E Kubista, G Wolf, H R Rosen and S Panzer
Br J Cancer 80: 874-878; doi:10.1038/sj.bjc.6690434
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables FREE
V Launonen, K Laake, P Huusko, D Niederacher, M W Beckmann, R B Barkardottir, E K Geirsdottir, J Gudmundsson, P Rio, Y-J Bignon, S Seitz, S Scherneck, I Bièche, M-H Champème, D Birnbaum, G White, J Varley, M Sztán, E Olah, A Osorio, J Benitez, N Spurr, N Velikonja, B Peterlin, Å Borg, A-M Cleton-Jansen, P Devilee, R Bloigu, R Lidereau, A-L Børresen-Dale, R Winqvist and the Breast Cancer Somatic Genetics Consortium
Br J Cancer 80: 879-882; doi:10.1038/sj.bjc.6690435
Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR FREE
T J de Vries, A Fourkour, C J A Punt, L T F van de Locht, T Wobbes, S van den Bosch, M J M de Rooij, E J B M Mensink, D J Ruiter and G N P van Muijen
Br J Cancer 80: 883-891; doi:10.1038/sj.bjc.6690436
Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients FREE
R Salgado, P B Vermeulen, I Benoy, R Weytjens, P Huget, E Van Marck and L Y Dirix
Br J Cancer 80: 892-897; doi:10.1038/sj.bjc.6690437
Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours FREE
V Speirs and S L Atkin
Br J Cancer 80: 898-903; doi:10.1038/sj.bjc.6690438
Somatic mutation of PTEN in bladder carcinoma FREE
J S Aveyard, A Skilleter, T Habuchi and M A Knowles
Br J Cancer 80: 904-908; doi:10.1038/sj.bjc.6690439
Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parents FREE
F Rinaldi, R J Mairs, T E Wheldon, F Katz, J M Chessells and B E Gibson
Br J Cancer 80: 909-913; doi:10.1038/sj.bjc.6690440
Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours FREE
Y Nakagawa, H Morikawa, I Hirata, M Shiozaki, A Matsumoto, K Maemura, T Nishikawa, M Niki, N Tanigawa, M Ikegami, K Katsu and Y Akao
Br J Cancer 80: 914-917; doi:10.1038/sj.bjc.6690441
Expression of CD44 by rhabdomyosarcoma: a new prognostic marker? FREE
G Humphrey, D L Hazel, K MacLennan and I Lewis
Br J Cancer 80: 918-921; doi:10.1038/sj.bjc.6690442
Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome FREE
G Boxer, S Stuart-Smith, A Flynn, A Green and R Begent
Br J Cancer 80: 922-926; doi:10.1038/sj.bjc.6690443
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
